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Abstract
Background: Limited experiences of applying an on-pump beating-heart technique for surgical revascularization in
patients with severe left ventricular dysfunction have been reported. Which strategy, either off-pump coronary artery
bypass grafting (CABG) or on-pump beating-heart CABG surgery, is the best strategy for surgical revascularization in
patients with severe left ventricular dysfunction is still controversial. This single-center study aimed to evaluate the
impacts of an on-pump beating-heart versus an off-pump technique for surgical revascularization on the early clinical
outcomes in patients with a left ventricular ejection fraction (LVEF) of 35% or less to explore which technique would be
more suitable for surgical revascularization in patients with severe left ventricular dysfunction.
Methods: A total of 216 consecutive patients with an echocardiographic estimated LVEF of 35% or less who
underwent non-emergency, primary, isolated CABG from January 2010 to December 2014 were included in this study
and were divided into either an ONBEAT group (patients who received on-pump beating-heart CABG surgery, n = 88)
or an OFF group (patients who received off-pump CABG surgery, n = 128). The early clinical outcomes were
investigated and compared.
Results: Patients in the ONBEAT group compared to the OFF group had a significant higher early postoperative LVEF
(35.6 ± 2.9 vs. 34.8 ± 3.3%, p = 0.034) but shared a similar baseline LVEF (31.0 ± 2.8 vs. 31.0 ± 2.9%, p = 0.930). Patients in
the ONBEAT group compared to the OFF group received a greater number of grafts and an increased amount of
drainage during the first 24 h (3.7 ± 0.8 vs. 2.8 ± 0.6, p <0.001; 715 ± 187 ml vs. 520 ± 148 ml, p <0.001, respectively),
without evidence of worse in-hospital mortality or major postoperative morbidity. Additionally, logistic regression
analysis showed that surgical technique (on-pump beating-heart CABG vs. off-pump CABG) had no independent
influence on in-hospital mortality or major postoperative morbidity in patients with preoperative LVEF of 35% or less.
Conclusions: The on-pump beating-heart technique may be an acceptable alternative to the off-pump technique for
surgical revascularization in patients with an estimated LVEF of 35% or less.
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Background
With advances in instruments, myocardial protection and
surgical technology, both early and long-term outcomes of
surgical revascularization are increasingly improved. Con-
sequently, a growing number of high-risk patients suffer-
ing from coronary artery disease are expected to be
treated with surgical revascularization [1–5].
Off-pump coronary artery bypass grafting (CABG),
which avoids the use of cardiopulmonary bypass with car-
dioplegic arrest and aortic cross-clamp, has attracted the
interest of an increasing number of cardiac surgeons and
patients scheduled for surgical revascularization [6, 7].
Although most proponents of off-pump surgery have
advocated the off-pump technique as a suitable strategy
for surgical revascularization, patients with severe left ven-
tricular dysfunction undergoing off-pump CABG surgery
are at risk for intra-operative hemodynamic deterioration
and incomplete revascularization, which increases the in-
cidence of postoperative morbidity and mortality [8]. Even
if a combined application of an intra-aortic balloon pump
(IABP), morbidity and mortality after off-pump CABG
surgery may remain high in patients with severe left
ventricular dysfunction due to intra-operative hemo-
dynamic deterioration resulting from inadequate circu-
latory support (IABP support increases the cardiac
output up to approximately 17% in the case of severe
pump failure) [9, 10].
On-pump beating-heart CABG, which uses cardiopul-
monary bypass without either cardioplegic arrest or aortic
cross-clamp, has recently been applied in high-risk
patients [11–19]. Cardiopulmonary bypass offers enough
circulatory support and ensures intra-operative hemo-
dynamic stability more than IABP support does. Assisted
by cardiopulmonary bypass, the optimal exposure of the
target coronary artery can be obtained due to perfect car-
diac decompression, which contributes to complete revas-
cularization. However, despite avoiding the disadvantages
resulting from cardioplegic arrest and aortic cross-clamp,
on-pump beating-heart CABG is associated with postop-
erative morbidity related to the use of cardiopulmonary
bypass [15]. Additionally, limited experiences of applying
an on-pump beating-heart technique for surgical revascu-
larization in high-risk patients with severe left ventricular
dysfunction have been reported.
Which strategy, either off-pump CABG surgery or on-
pump beating-heart CABG surgery, is the best strategy for
surgical revascularization in patients with severe left ven-
tricular dysfunction is still controversial. Few reports have
focused on evaluating the impacts of an on-pump
beating-heart versus an off-pump technique for surgical
revascularization on the clinical outcomes in patients with
a left ventricular ejection fraction (LVEF) of 35% or less.
This single-center, retrospective study reviewed 216 con-
secutive patients with an echocardiographic estimated
LVEF of 35% or less who underwent non-emergency, pri-
mary, isolated CABG surgery, and evaluated the impacts
of the on-pump beating-heart approach versus the off-
pump technique on the early clinical outcomes to explore
which technique would be more suitable for surgical re-




Patients undergoing non-emergency, primary, isolated
CABG surgery with graftable double- or triple- vessel
disease and severe left ventricular dysfunction were eli-
gible for this study. In this study, severe left ventricular
dysfunction was defined an echocardiographic estimated
LVEF of 35% or less using a modified Simpson method.
Exclusion criteria included concomitant left ventricle
aneurysm, concomitant post-infarction ventricular septal
defect, concomitant medium to severe mitral regurgita-
tion or aortic regurgitation, and concomitant acquired
or congenital cardiac or aortic surgery.
All included patients were allocated to either an
ONBEAT group (patients received on-pump beating-
heart CABG surgery) or an OFF group (patients under-
went off-pump CABG surgery). The decision to perform
on-pump beating-heart or off-pump CABG was influ-
enced by each patient’s demographic and clinical profile
(i.e., age, diabetes mellitus, renal function, left ventricu-
lar endo-diastolic diameter, and estimated surgical risks),
but the choice was ultimately left to the discretion of the
operating surgeon. In our center, off-pump CABG sur-
gery was performed routinely for over 10 years before
the launch of the trial, and all surgical revascularization
procedures in high-risk patients were performed by 3
surgeons who were highly experienced in both off-pump
and on-pump CABG surgery (each of the 3 surgeons
performed at least 50% of their CABG procedures as off-
pump CABG with an annual CABG procedure volume
of over 150 cases). Patients were regularly followed up at
1 and 6 months after discharge.
Surgical procedures
All patients underwent CABG through a median full-
sternotomy. The in situ left internal mammary artery,
which was skeletonized or dissected as a pedicle according
to the surgeon’s preference, was always preferred as the
first choice for revascularization of the left anterior de-
scending coronary territory whenever feasible. Saphenous
vein grafts and radial arteries were harvested with an open
technique. The choices of using grafting conduits and
employing a sequential technique for the secondary target
vessels were affected by the target coronary territories (i.e.,
right coronary and left circumflex), graft conduit
availability, and the surgeon’s preference concerning these
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factors for achieving complete revascularization. An
eNclose (Novare Surgical Systems Inc., American) or even
“no-touch” aorta technique was available when moderate
to severe ascending aortic sclerosis or calcification was
detected. The quality of anastomosis was assessed after
grafting with a transit-time flow probe (Medistim Butterfly
Flow Meter, Oslo, Norway).
For patients receiving off-pump CABG, heparin was
given to reach an ACT of more than 300 s. The central
temperature was maintained above 36 °C to avoid
hypothermia-induced ventricular arrhythmia. The heart
was displaced using a posterior pericardial stitch and large
(12 × 70 cm) gauze swabs. Patients lacking good presenta-
tion of the target arteries on the lateral and inferior aspect
of the heart were placed in a gentle right decubitus
Trendelenburg position to assist in visualization. Stabliza-
tion of the target coronary arteries was accomplished with
a tissue stabilizer (Octopus, Medtronic Corporation,
Minneapolis, MN). Meanwhile, medical reduction of heart
rate and myocardial contractility was performed with a
short-acting beta-blocker. A CO2-blower/NaCl mister de-
vice was used in situations in which a bloodless field was
not achieved with proximal target vessel occlusion. An
intra-coronary shunt (Medtronic Corporation, Minneapolis,
MN) was used during grafting when necessary. Blood loss
was collected with a cell salvage device, and the salvaged
blood was re-infused into the patient before completion of
the surgery.
For patients undergoing on-pump beating-heart
CABG, cardiopulmonary bypass was instituted by can-
nulating the ascending aorta and right atrium after sys-
temic heparinization (3 mg/kg) with a target activated
clotting time of more than 480 s without either cardio-
plegic arrest or an aortic cross-clamp. Moderate hemo-
dilution (hematocrit, 20 to 25%) and no cooling were
used during cardiopulmonary bypass. Standard manage-
ment included membrane oxygenators, arterial catheter
filters, and a non-pulsatile flow of 2.4 L/min/m2 with a
mean arterial blood pressure greater than 50 mmHg.
The same exposure, stabilization, and immobilization
techniques to allow exposure of the lateral, posterior,
and inferior walls of the heart used during off-pump
CABG were applied. A CO2-blower/NaCl mister device
and an intra-coronary shunt were used during grafting
when necessary. After the cardiopulmonary bypass was
discontinued, heparin was neutralized with 1 mg pro-
tamine sulfate per 1 mg provided.
End point
The primary end point was in-hospital mortality, which
was defined as death occurring during the hospital-
ization at which the operation was performed, even if
death occurred after 30 days or after discharge from
the hospital but within 30 days of the procedure,
unless the cause of death was clearly unrelated to the
operation.
The secondary end point was the occurrence of major
postoperative morbidity, including circulatory morbidity
(i.e., low cardiac output syndrome (LCOS) and new on-
set of acute myocardial infarction), pulmonary complica-
tions (i.e., pneumonia and respiratory failure), renal
failure requiring hemodialysis, stroke, re-operation for
bleeding, and deep sternal wound infection. Postopera-
tive LCOS was defined as the requirement for IABP
and/or inotropic support for inability to discontinue car-
diopulmonary bypass or for longer than 30 min after the
patient was returned to intensive care unit to maintain
the systolic blood pressure >90 mmHg and the cardiac
index >2.2 L/min/m2 [20]. New onset of acute myocar-
dial infarction after the operation was defined any new
Q wave or disappearance of an R wave on a postopera-
tive electrocardiogram within 24 h of the operation [21].
Postoperative pneumonia was defined as a positive result
in a sputum culture requiring anti-infection treatment,
or a chest X-ray diagnosing pneumonia following cardiac
surgery. Postoperative respiratory failure was defined as
a duration of mechanical ventilation for more than 72 h
or re-intubation following cardiac surgery. Postoperative
stroke was defined as a new focal or global dysfunction
of cerebral function lasting over 24 h. Deep sternal
wound infections (bone-related or any drainage of puru-
lent material from the sternotomy wound and instability
of the sternum) were recorded. In addition, the length of
ICU stay, the amount of drainage during the first 24 h,
the duration of mechanical ventilation, and IABP sup-
port (prophylactic preoperative application and applica-
tion on an “as needed” basis) were also recorded. The
decision to prophylactic preoperative IABP application
was influenced by each patient’s demographic and clin-
ical profile (i.e. estimated surgical risks, hemodynamic
instability before grafting, etc.), but the choice was ul-
timately left to the discretion of the operating surgeon.
Patients were installed with an IABP when they were
inability to discontinue cardiopulmonary bypass after
grafting or developed low cardiac output after CABG
surgery (application of IABP on an “as needed” basis).
Statistical analysis
This was a single-center, retrospective study. This study
protocol was approved by the ethics committee of
Zhongshan Hospital Fudan University and was consist-
ent with the Declaration of Helsinki. Peri-operative data
were obtained from our institutional database and
reviewed using a standard data collection form.
Normally distributed continuous variables were ex-
pressed as the mean ± standard deviation and were
compared between groups using the Student’s t-test. Non-
normally distributed continuous variables were expressed
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as median and quartiles and were compared between the
groups with the Wilcoxon rank sum test. Categorical vari-
ables were expressed as frequency distributions and single
percentages, and they were compared between groups
using χ2 test and Fisher’s exact test, when appropriate. An
in-hospital survival analysis was conducted using the
Kaplan-Meier method with a log-rank test for group com-
parisons. To further confirm the reliability of the results,
in-hospital mortality and major postoperative morbidity
were further analyzed using a multivariate logistic regres-
sion analysis. The covariate of regression analysis included
age, gender, smoking, past medical history (including
diabetes, hyperlipemia, hypertension, chronic obstructive
pulmonary disease, chronic renal dysfunction, cerebro-
vascular accident, myocardial infarction, congestive heart
failure, and peripheral vascular disease), left ventricular
ejection fraction, left ventricular end-diastolic diameter,
and the number of grafts. A value of two-sided p less than
0.05 was considered statistically significant. Statistical ana-
lysis was performed with SPSS statistical package version
17.0 (SPSS Inc., Chicago, IL, USA).
Results
Study population
From January 2010 to December 2014, 257 patients with
double- or triple- vessel coronary artery disease met the
inclusion criteria and accounted for 7.0% of all patients
with coronary artery disease who received CABG
surgery. Forty-one patients were excluded due to a
concomitant left ventricle aneurysm in 20 patients, a
concomitant medium to severe mitral regurgitation or
aortic regurgitation in 18 patients, and a concomitant
post-infarction ventricular septal defect in 3 patients.
Finally, 216 patients (45 females, mean 65.5 ± 8.1 years
of age) were analyzed with their LVEF varying from
18–35% (31.0 ± 2.9%). Among these patients, 88 patients
who received on-pump beating-heart CABG were in-
cluded in the ONBEAT group, and the remaining 128
patients who received off-pump CABG were included in
the OFF group.
The baseline characteristics of the entire cohort are
shown in Table 1. Patients in the ONBEAT group were
more likely to present with diabetes and a larger left ven-
tricular endo-diastolic diameter, and they had a higher
proportion of enlarged left ventricles compared to the
OFF group (37.5 vs. 24.2%, p = 0.048; 66.8 ± 6.0 mm vs.
64.8 ± 5.6 mm, p = 0.013; and 56.8 vs. 39.8%, p = 0.018,
respectively). Eighteen patients in the OFF group received
prophylactic preoperative IABP support, whereas no
patients in the ONBEAT group received prophylactic pre-
operative IABP support (p <0.001). No significant differ-
ences emerged between the 2 groups in age and the
proportions of older age, gender, recent smoking, chronic
obstructive pulmonary disease, hypertension, diabetes,
hyperlipemia, chronic renal dysfunction, prior cerebro-
vascular accident, history of percutaneous coronary inter-
vention, recent myocardial infarction, congestive heart
failure, the extent of coronary artery disease, left main cor-
onary artery disease, left ventricular ejection fraction, and
a Euro-SCORE >6.0.
Intra-operative data
The number of bypass conduits ranged from 2 to 6. The
left internal mammary artery was used as a bypass con-
duit in 216 patients (100%), the right internal mammary







Age (years) 66.0 ± 7.9 65.2 ± 8.2 0.509
Older age (age >65 years) 54 (61.4%) 75 (58.6%) 0.778
Gender (Female) 18 (20.5%) 27 (21.1%) 1.000
Recent smoking 17 (19.3%) 21 (16.4%) 0.859
COPD 11 (12.5%) 17 (13.3%) 1.000
Hypertension 48 (54.5%) 73 (57.0%) 0.781
Diabetes 33 (37.5%) 31 (24.2%) 0.048
Hyperlipemia 13 (14.8%) 19 (14.8%) 1.000
Chronic renal dysfunction 2 (2.3%) 5 (3.9%) 0.703
Prior CVA 7 (8.0%) 17 (13.3%) 0.274
History of PCI 16 (18.2%) 24 (18.8%) 1.000
Recent MI 22 (25.0%) 28 (21.9%) 0.625
Congestive heart failure 25 (28.4%) 38 (29.7%) 0.879
Extent of CAD
2 vessel 4 (4.5%) 12 (9.4%) 0.290
3 vessel 84 (95.5%) 116 (90.6%)
LM 26 (29.5%) 33 (25.8%) 0.641
LVEF (%) 31.0 ± 2.8 31.0 ± 2.9 0.930
LVEDD (mm) 66.8 ± 6.0 64.7 ± 5.9 0.013
Enlarged left ventricles
(LVEDD > 65 mm)
50 (56.8%) 51 (39.8%) 0.018
Prophylactic IABP support 0 18 (14.1%) <0.001
Euro-SCORE >6.0 44 (50.0%) 61 (47.7%) 0.782
Intra-operation
Number of grafts 3.7 ± 0.8 2.8 ± 0.6 <0.001
CPB time (min) 83.7 ± 7.7 0 <0.001
Urgent switch to on-pump 0 5 (3.9%) 0.081
Group ONBEAT patients received on-pump beating-heart coronary artery bypass
grafting, Group OFF patients underwent off-pump coronary artery bypass grafting,
COPD chronic obstructive pulmonary disease, CVA cerebro-vascular accident,
PCI percutanous coronary intervention, MI myocardial infarction, CAD coronary
artery disease, LM left main trunk disease, LVEF left ventricular ejection fraction,
LVEDD left ventricular end-diastolic diameter, IABP intra-aortic balloon pump,
Euro-SCORE European system for cardiac operative risk evaluation,
CPB cardiopulmonary bypass
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artery was used as a graft for 70 patients (32.4%), a radial
artery graft was used for 32 patients (14.8%) and a sa-
phenous vein graft was used for 198 patients (91.7%).
Patients in the ONBEAT group compared to the OFF
group received a greater number of grafts (3.7 ± 0.8 vs.
2.8 ± 0.6, p = 0.000). The duration of cardiopulmonary
bypass in the ONBEAT group was 83.7 ± 7.7 min. Five
patients (3.9%) scheduled for off-pump CABG surgery
had to be switched urgently to on-pump beating-heart
CABG surgery due to hemodynamic deterioration or fre-
quent ventricular fibrillation during the operation.
Preoperative and early postoperative LVEF
Mean LVEF, as measured preoperatively and early post-
operatively (before discharge), significantly improved
from 31.0 ± 2.8 to 35.6 ± 2.9% (p <0.001) in the ONBEAT
group and from 31.0 ± 2.9 to 34.8 ± 3.3% (p <0.001) in
the OFF group, respectively. Patients in the ONBEAT
group compared to the OFF group had a significant
higher early postoperative LVEF (35.6 ± 2.9 versus
34.8 ± 3.3%, p = 0.034) but shared a similar baseline
LVEF (31.0 ± 2.8 versus 31.0 ± 2.9%, p = 0.930).
In-hospital mortality and major postoperative morbidity
Nine patients died during the same hospitalization or
within 30 days of the operation, and the in-hospital mor-
tality was 4.2%. The causes of death were as follows: low
cardiac output in 4 patients, infection in 2 patients, ma-
lignant arrhythmia in 1 patient, cerebral hemorrhage in
1 patient, and gastrointestinal bleeding in 1 patient.
Patients in the ONBEAT group compared to the OFF
group had a slightly lower in-hospital mortality, but no
significant difference was found (3.4 vs. 4.7%, p = 0.741).
Additionally, 2 patients out of 5 patients undergoing ur-
gent switching from off-pump to on-pump beating-heart
CABG surgery died as follows: one died of postoperative
low cardiac output, and the other died of malignant
arrhythmia.
The major postoperative morbidity is summarized in
Table 2. Patients in the ONBEAT group compared to the
OFF group had a low circulatory morbidity, including
low incidences of postoperative low cardiac output syn-
drome and new onset of acute myocardial infarction, but
no significant differences were found (12.5 vs. 19.5%,
p = 0.197; 3.4 vs. 3.9%, p = 1.000, respectively). There was
no significant difference in the proportion of application
of IABP support on an “as needed” basis between the 2
groups (12.5 vs. 19.5%, p = 0.197). After an IABP insertion,
4 patients out of 54 patients developed either limb
ischemia or hematoma at the site of IABP insertion. All 4
patients recovered after discontinuation of IABP. There
were no IABP-related deaths.
Patients in the ONBEAT group compared to the OFF
group had a slightly higher incidence of postoperative
pulmonary complications, including slightly higher inci-
dences of pneumonia and respiratory failure, but no sig-
nificant differences emerged (11.4 vs. 9.4%, p = 0.653;
15.9 vs. 8.6%, p = 0.129, respectively). Patients in the
ONBEAT group compared to the OFF group had pro-
longed mechanical ventilation, but no significant differ-
ences emerged (median, 29 vs. 28 h, p = 0.483).
Patients in the ONBEAT group compared to the OFF
group had a low incidence of renal failure requiring
hemodialysis and high incidences of stroke and deep ster-
nal wound infection, but no significant differences
emerged. Despite an significantly increased amount of
drainage during the first 24 h (715 ± 187 vs. 520 ± 148 ml,
p <0.001), patients in the ONBEAT group had a similar
incidence of re-operation for bleeding compared to the
OFF group (3.4 vs. 3.1%, p >0.05). Additionally, the 2
groups had a similar length of ICU stay (4.0 ± 3.1 vs.
3.9 ± 1.9 d, p = 0.517).
The impacts of surgical technique (on-pump beating-
heart CABG vs. off-pump CABG) on in-hospital mortal-
ity and major postoperative morbidity after adjusting for
potential confounders (i.e., age, gender, smoking, dia-
betes, hyperlipemia, hypertension, chronic obstructive
pulmonary disease, chronic renal dysfunction, cerebro-
vascular accident, myocardial infarction, congestive heart
failure, left ventricular ejection fraction, left ventricular
end-diastolic diameter, and the number of grafts) are






In-hospital mortality 3 (3.4%) 6 (4.7%) 0.741
Circulatory morbidity
LCOS 11 (12.5%) 25 (19.5%) 0.197
New onset of acute MI 3 (3.4%) 5 (3.9%) 1.000
IABP support on an “as needed”
basis
11 (12.5%) 25 (19.5%) 0.197
Drainage during the first 24 h (ml) 715 ± 187 520 ± 148 0.000
Re-operation for bleeding 3 (3.4%) 3 (2.3%) 0.689
Pulmonary complications
Pneumonia 10 (11.4%) 12 (9.4%) 0.653
Respiratory failure 14 (15.9%) 11 (8.6%) 0.129
Duration of MV (h, median) 29 28 0.483
Renal failure requiring hemodialysis 3 (3.4%) 4 (3.1%) 1.000
Stroke 5 (5.7%) 5 (3.9%) 0.533
Deep sternal wound infection 4 (4.5%) 5 (3.9%) 1.000
Length of ICU stay (d) 4.0 ± 3.1 3.9 ± 1.9 0.517
LVEF before discharge (%) 35.6 ± 3.1 34.8 ± 3.3 0.034
Group ONBEAT patients received on-pump beating-heart coronary artery
bypass grafting, Group OFF patients underwent off-pump coronary artery
bypass grafting, LCOS low cardiac output syndrome, MI myocardial infarction,
IABP intra-aortic balloon pump, MV mechanic ventilation, ICU intensive care
unit, LVEF left ventricular ejection fraction
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shown in Table 3. In multivariate logistic regression ana-
lysis, surgical technique (on-pump beating-heart CABG
vs. off-pump CABG) had no independent influence on
in-hospital mortality or major postoperative morbidity.
Discussion
The major finding of the current study was that patients
in the ONBEAT group compared to the OFF group re-
ceived an increased amount of drainage during the first
24 h, a greater number of grafts, and a more improved
LVEF, without evidence of worse in-hospital mortality or
major postoperative morbidity. In this study, patients in
the ONBEAT group compared to the OFF group re-
ceived an increased amount of drainage during the first
24 h. The reason may be related to cardiopulmonary by-
pass and heparinization during on-pump beating-heart
CABG surgery. Although an increased amount of drain-
age occurred during the first 24 h, the 2 groups shared a
similar incidence of re-operation for bleeding. Patients
in the ONBEAT group compared to the OFF group re-
ceived a greater number of grafts, which may have been
be result of optimal exposure of the target coronary
artery due to perfect cardiac decompression with the
support of cardiopulmonary bypass. Patients in the
ONBEAT group compared to the OFF group had a sig-
nificant higher early postoperative LVEF but shared a
similar baseline LVEF, suggesting that patients in the
ONBEAT group received a more improved LVEF after
CABG surgery. It meant that patients with severe left
ventricular dysfunction may have more benefits from
on-pump beating-heart CABG surgery. The reason may
be related to a greater number of grafts in the ONBEAT
group compared to the OFF group. Although there was
no significant difference, patients in the ONBEAT group
compared to the OFF group had a slightly low incidence
of circulatory morbidity. The reasons may be that the
surgical technique and cardiopulmonary bypass can offer
enough circulatory support and ensure hemodynamic
stability during on-pump beating-heart CABG surgery.
A low incidence of circulatory morbidity may also be re-
lated to complete revascularization, which was revealed
in this study when patients in the ONBEAT group re-
ceived a greater number of grafts compared to the OFF
group. Although there was no significant difference,
patients in the ONBEAT group compared to the OFF
group had a slightly higher incidence of postoperative
pulmonary complications. The reason for high incidence
of pulmonary complications may be related to the appli-
cation of extracorporeal circulation during on-pump
beating-heart surgery.
Previous studies have investigated the on-pump
beating-heart technique for surgical revascularization.
Even by 2005, Rastan and colleagues [17] had prospect-
ively examined randomized data of markers of myocar-
dial injury in 20 patients with a normal ejection fraction
who underwent off-pump CABG compared to 20 pa-
tients with a normal ejection fraction who underwent
on-pump beating-heart CABG, and they showed off-
pump CABG had less myocardial injury than on-pump
beating-heart CABG. This evidence differed from the re-
sults of this study. The reason for this difference may
have been the study population because the current
study focused on high-risk patients with left ventricular
ejection fraction of 35% or less. Gulcan and colleagues
[12] evaluated myocardial function and clinical outcomes
of 46 high-risk patients with an ejection fraction <30%
who received on-pump beating-heart CABG and associ-
ated procedures, and they found that the on-pump
beating-heart CABG technique was effective for pro-
tecting myocardial functions in patients with severe left
ventricular dysfunction and was associated with low post-
operative morbidity and mortality. This evidence agreed
with the outcomes of the current study. Another study
[22], including patients with a high-risk Euro-SCORE and
with a mean EF of 0.37, revealed that the on-pump
beating-heart method seemed to be safe, secure and ef-
fective for this population of very high-risk patients and
conducive to complete revascularization, reducing early
complications and multi-organ failure compared to off-
pump CABG. This evidence also agreed with the out-
comes of this study. A recent study [23] investigated the
early outcomes associated with survival, morbidity and
improvement of left ventricular function in 66 high-risk
patients with a mean ejection fraction of 0.27 undergoing
conventional CABG and 65 high-risk patients with a mean
ejection fraction of 0.28 undergoing on-pump beating-
heart CABG, and showed that the on-pump beating-heart
technique may be an acceptable alternative to the conven-
tional technique due to lower postoperative mortality and
morbidity, and the on-pump beating-heart approach was
Table 3 Impacts of surgical techniques on mortality and morbidity
Events Group OFF Group ONBEAT
In-hospital mortality 1.0 0.75 (0.38–2.16)
LCOS 1.0 0.61 (0.31–1.86)
New onset of acute MI 1.0 0.65 (0.34–2.05)
Pneumonia 1.0 1.31 (0.72–3.85)
Respiratory failure 1.0 1.75 (0.83–4.86)
Renal failure 1.0 0.78 (0.41–2.24)
Stroke 1.0 2.18 (0.93–5.79)
Re-operation for bleeding 1.0 1.11 (0.58–3.25)
Deep sternal wound infection 1.0 1.25 (0.63–3.84)
IABP support on an “as needed” basis 1.0 0.62 (0.33–1.98)
Group OFF patients underwent off-pump coronary artery bypass grafting,
Group ONBEAT patients received on-pump beating-heart coronary artery
bypass grafting, LCOS low cardiac output syndrome, MI myocardial infarction,
IABP intra-aortic balloon pump
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the preferred method for surgical revascularization in
high-risk patients with severe left ventricular dysfunction.
This evidence was in line with the outcomes of the
current study. Additionally, the results obtained by
Darwazah [15] suggested that on-pump beating-heart
CABG was more effective in high-risk patients with better
myocardial revascularization, but it also had a higher inci-
dence of postoperative morbidity and mortality compared
to off-pump CABG. This evidence was in line with
evidence from this study of better myocardial revasculari-
zation but was different from the incidence of postopera-
tive morbidity and mortality.
In this study, patients in the ONBEAT group had a
higher proportion of diabetes compared to the OFF
group. The reason may be partly related to the relatively
small target coronary artery in diabetic patients. In
addition to a small target coronary artery, diabetic
patients had more serious and diffuse coronary artery
disease compared to the non-diabetic patients. On-
pump beating-heart CABG compared to off-pump
CABG provides optimal exposure of the target coronary
artery and may be the preferred choice for diabetics who
required surgical revascularization. This study also
showed patients in the ONBEAT group compared to the
OFF group had a larger left ventricular endo-diastolic
diameter and had a higher proportion of enlarged left
ventricles, which may be related to the surgical field be-
cause the on-pump beating-heart technique provided
optimal exposure of the target coronary artery due to
perfect cardiac decompression with the support of car-
diopulmonary bypass. Patients in the OFF group com-
pared to the ONBEAT group received a higher
proportion of prophylactic preoperative IABP applica-
tion, suggesting that due to the lack of circulatory sup-
port, more high-risk patients with severe left ventricular
dysfunction who were scheduled for off-pump CABG
surgery required prophylactic use of IABP support. Add-
itionally, 5 patients undergoing urgent switching from
off pump to on-pump received cardiopulmonary bypass,
but they were still allocated to the OFF group, which
may produce biased results. However, due to hemo-
dynamic deterioration or frequent ventricular fibrillation
during off-pump CABG surgery, they had to be switched
urgently to on-pump beating-heart CABG surgery.
Finally, 2 patients out of 5 patients died of low cardiac
output or malignant arrhythmia in the peri-operative
period. Thus, this result suggested that the on-pump
beating-heart approach compared to the off-pump
approach may be an suitable choice for patients with
severe left ventricular dysfunction and unstable hemo-
dynamics during the operation.
This study showed that on-pump beating-heart CABG
compared to off-pump CABG had some advantages,
including a more improved LVEF, a greater number of
grafts, and a slightly lower incidence of postoperative
circulatory morbidity. However, on-pump beating-heart
CABG had drawbacks associated with cardiopulmonary
bypass, including slightly higher incidences of post-
operative pulmonary complications and stroke and an
increased amount of drainage during the first 24 h.
Additionally, this study was only a single-center, retro-
spective study that involved a small sample size. It was
very difficult to develop an algorithm for the use of on-
pump beating-heart CABG as a standard procedure for
surgical revascularization in patients with severe left
ventricular dysfunction. The decision about using an on-
pump beating-heart or an off-pump technique for
surgical revascularization in patients with severe left
ventricular dysfunction should be tailored individually to
achieve the greatest clinical benefits for patients. For
example, a diabetic patient with a left ventricular endo-
diastolic diameter of 70 mm and an echocardiographic
estimated LVEF of 25% may have more benefits from
on-pump beating-heart CABG surgery, whereas a pa-
tient with severe chronic obstructive pulmonary disease
and an echocardiographic estimated LVEF of 35% may
benefit from off-pump CABG surgery with or without
an IABP support.
There were several limitations to this study. First, it
was a single center, retrospective clinical observational
study that involved a small sample size, which may have
influenced the generalizability of the results. A final de-
termination would need a multi-center study involving a
larger sample size. Second, because these were high-risk
patients with severe left ventricular dysfunction, this pa-
tient group may have produced considerable bias. Third,
due to a retrospective clinical observational study, the
time course of changes in the serum levels of markers of
myocardial injury, e.g., cardiac troponin I, were not
dynamically monitored. Finally, this study only focused
on evaluating the impacts of the on-pump beating-heart
technique vs. the off-pump technique for surgical revas-
cularization on the early clinical outcomes in patients
with an LVEF of 35% or less. The medium and long term
clinical outcomes needed a further observation.
Conclusion
The on-pump beating-heart technique may be an
acceptable alternative to the off-pump technique for
surgical revascularization in patients with severe left
ventricular dysfunction due to a greater number of grafts
and a more improved LVEF after CABG without evi-
dence of worse in-hospital mortality or major post-
operative morbidity. Nevertheless, this study was only a
single-center, retrospective, non-randomized clinical
observational trial that involved a small sample size.
Multi-center, controlled and randomized clinical trials
involving larger sample sizes are needed.
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